Measles Incidence in United States Remains, But Need to Vaccinate Stays HighMeasles is still very rare in the United States, but most cases involved either someone who was not vaccinated or whose status is unknown.
Small Doses: Pharmacy News Featuring Vaccine Skeptics, an Aspirin-Cancer Link, and More
Small Doses: Pharmacy News Featuring Vaccine Skeptics, an Aspirin-Cancer Link, and MoreEasy-to-swallow bits of news from around the world of pharmacy.
Stronger Measles Vaccination Exemption Policies Reduce the Likelihood of an OutbreakMaking nonmedical vaccination exemptions more difficult to obtain can reduce risk of a measles epidemic.
Stopping the measles outbreak
Stopping the measles outbreakMeasles has long been one of the leading causes of childhood blindness worldwide, but with the recent U.S. outbreak—due to a decrease in vaccination compliance for the disease—many parents nationwide are growing concerned. While there are no specific anti-viral treatments for the disease, there are several crucial ways ophthalmologists can stop the outbreak in its tracks, according to David Hunter, MD, PhD.
Measles re-emergesHealth plans and providers play a critical role in maintaining U.S. vaccination rates and can help reverse the recent MMR vaccination-rate decline, a factor responsible for the recent re-emergence of measles.
Vaccine wars
Vaccine warsThe ongoing US measles outbreak underscores the importance of childhood vaccines—opponents of vaccination notwithstanding, say experts.
Formulary managers can help improve vaccination rates
Formulary managers can help improve vaccination ratesManaged care and hospital decision-makers are in a key position to “move the needle” at the system level on improving adult immunization coverage rates in the United States.
Measles makes a comebackBetween January 1 and October 31 of this year, the Centers for Disease Control and Prevention confirmed 603 cases of measles in 22 states—the highest number since 1994—marking a striking resurgence of a disease that was declared eliminated in the United States in 2001.
Melanoma mortality rate 5 times higher in developed countriesWhen researchers studied mortality from conditions with skin manifestations in developed versus developing countries, they found living in the developed world doesn’t always translate to lower death rates. Age-adjusted mortality for melanoma, for example, was about five times greater in the developed world than in developing countries.
Nurses play key role in vaccination successNurses are on the front line when it comes to battling the resurgence of diseases like pertussis and measles.